Patients Community pharmacy is ready to lead. Now it needs the system... Community pharmacy is the infrastructure that makes NHS long-term plans and ambitions possible. But infrastructure without investment does not hold.
Patients Stem the bleeding: Rising to meet the growing demand for CGT... Following World Blood Donor Day, a look at the continued need for more donors of blood, but also cord blood and perinatal tissue, too.
Patients The forgotten few: Why the kidney transplant system is faili... While innovation has reshaped therapeutic areas like oncology, transplant medicine has, by comparison, stood still.
Patients ASCO 2026: Quality of life, not just quantity, with Dr Harol... Dr Harold Keer, chief medical officer at Taiho Oncology, goes in-depth about why his company places such an emphasis on oral formulations.
Patients Biosimilars & patient access independent of geographies or s... Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.
Patients ASCO 26: Three cancer survivors share lessons for the field In honour of National Cancer Survivors' Day, we recount three patient testimonies and calls to action from ASCO Voices at ASCO 2026.
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.